15 results
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... and Management Initiative ... , Agents and Dosing ... #Pain #Pharmacology ... #Medications #Doses
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... - Transdermal Medications ... Pain #Pharmacology ... Transdermal #Topical #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Procedural Sedation and Analgesia Medications 

#Management #Pain #Pharmacology #PSA
Pain Assessment ... and Analgesia Medications ... #Pain #Pharmacology ... Sedation #Analgesia #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... #Management # ... Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: ... #Pain #Pharmacology ... #Neuropathic #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... #Management # ... Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing
Hydroxychloroquine and Chloroquine in COVID19

Dosing:
Hydroxychloroquine:
 - 400mg PO BID on the first day, followed by 200mg
Chloroquine in COVID19 ... Dosing: Hydroxychloroquine ... #Chloroquine #COVID19 ... #HCQ #Pharmacology ... #Management #Medications
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... and Nebulized Medications ... #Management # ... Pain #Pharmacology ... Intranasal #Nebulized #Medications
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
like illnesses, COVID ... all extremity, facial ... support (10-30%) • Facial ... Hands or feet • Pain ... Syndrome #diagnosis #management
Pearls for Treatment of Alcohol Use Disorder

First-line pharmacotherapies for moderate to severe AUD include naltrexone and
include abdominal pain ... high risk for using ... #UseDisorder #Management ... Screening #Addiction #Medications ... #Pharmacology